Study identifies potential immunotherapy strategy for early-stage prostate cancer
March 4, 2026
Study identifies potential immunotherapy strategy for early-stage prostate cancer
PHOENIX (AP): A multi-institutional study led by Mayo Clinic and published in Cell Reports Medicine reports that pairing a next-generation immunotherapy with standard hormone therapy before surgery may help overcome a long-standing barrier in early-stage prostate cancer treatment.